MARATTO

article · Inflammopharmacology

Modulatory effects of bioactive natural compounds on pruritic pathways: mechanistic basis and therapeutic prospects

20251 citationOpen accessHeliopolis University

Abstract

Chronic pruritus, characterized by persistent itching, is a significant health issue that adversely affects individuals' quality of life, particularly in palliative care environments. Conventional treatments frequently do not yield sufficient relief and may lead to undesirable side effects, which has spurred interest in exploring alternative therapeutic options. A thorough literature search was conducted across several databases such as PubMed, Web of Science, Scopus, and EKB, with an emphasis on studies involving in vitro, animal models, and clinical trials utilizing terms like "plant," "extract," and "pruritus." All studies were considered regardless of their publication date and were limited to English-language articles. This review highlights the promise of various medicinal plants, including chamomile, Aloe vera, calendula, curcumin, lavender, licorice, and peppermint, as adjunctive therapies for pruritus. These plants possess a range of pharmacological properties, such as anti-inflammatory, antioxidant, and skin-soothing effects, which are relevant to the complex nature of pruritus. Their favorable safety profiles and natural origins enhance their appeal in holistic and patient-centered care models.

Research topics

  • Dermatology and Skin Diseases
  • Herbal Medicine Research Studies
  • Pharmacological Effects of Natural Compounds

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.1007/s10787-025-01999-1

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.